Evidence map›Paper›PMID 37876961›Full record

ArticleFrontiers in artificial intelligence2023

Stacked ensemble deep learning for pancreas cancer classification using extreme gradient boosting.

Wilson Bakasa, Serestina Viriri

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wilson BakasaSchool of Mathematics Statistics & Computer Science, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Durban, South Africa.
Serestina ViririSchool of Mathematics Statistics & Computer Science, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Durban, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ensemble learning aims to improve prediction performance by combining several models or forecasts. However, how much and which ensemble learning techniques are useful in deep learning-based pipelines for pancreas computed tomography (CT) image classification is a challenge. Ensemble approaches are the most advanced solution to many machine learning problems. These techniques entail training multiple models and combining their predictions to improve the predictive performance of a single model. This article introduces the idea of Stacked Ensemble Deep Learning (SEDL), a pipeline for classifying pancreas CT medical images. The weak learners are Inception V3, VGG16, and ResNet34, and we employed a stacking ensemble. By combining the first-level predictions, an input train set for XGBoost, the ensemble model at the second level of prediction, is created. Extreme Gradient Boosting (XGBoost), employed as a strong learner, will make the final classification. Our findings showed that SEDL performed better, with a 98.8% ensemble accuracy, after some adjustments to the hyperparameters. The Cancer Imaging Archive (TCIA) public access dataset consists of 80 pancreas CT scans with a resolution of 512 * 512 pixels, from 53 male and 27 female subjects. A sample of two hundred and twenty-two images was used for training and testing data. We concluded that implementing the SEDL technique is an effective way to strengthen the robustness and increase the performance of the pipeline for classifying pancreas CT medical images. Interestingly, grouping like-minded or talented learners does not make a difference.

Indexed as

classificationdeep learninghyperparameterspancreas segmentationstacking ensembleXGBoost

Identifiers

PMID37876961
PMCPMC10591225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.